911108-81-1Relevant articles and documents
Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy
Bohn, Pierre,Le Fur, Nicolas,Hagues, Guillaume,Costentin, Jean,Torquet, Nicolas,Papamicael, Cyril,Marsais, Francis,Levacher, Vincent
experimental part, p. 2612 - 2618 (2009/10/30)
This work deals with the design of a "bio-oxidisable prodrug" strategy for the development of new central selective acetylcholinesterase inhibitors. This prodrug approach is expected to reduce peripheral anticholinesterase activity responsible for various
